Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Nat Rev Drug Discov 6:904916 (Erratum in: Nat Rev Drug Discov 7:185) Antons KA, Williams CD, Baker SK, Phillips PS (2006) Clinical perspectives of statin-induced rhabdomyolysis
Shaking it may temporarily hide the cloudiness by creating tiny air bubbles, but it does not fix the underlying stability issue
Novo Nordisk makes the drugs, and Medicare is expected to negotiate prices of all three in the next round
Dosage and frequency tailored to individual treatment plans
This exceeds the FDA-approved maximum weekly dose and puts you at serious risk of adverse events
Mechanism of action and novelty: Newer agents with more complex mechanisms such as dual or triple receptor agonists tend to be priced at a premium compared with established treatments
US$ 24.44
US$ 23.72
US$ 22.68
US$ 25.45
US$ 28.85
US$ 23.45
